Thioacetazone
Antitubercular medication
| Thioacetazone | |
|---|---|
|
|
Thioacetazone is an antibacterial medication primarily used in the treatment of tuberculosis (TB). It is known for its role in combination therapy for Mycobacterium tuberculosis, the bacterium responsible for TB. Thioacetazone is particularly noted for its use in resource-limited settings due to its cost-effectiveness.
Chemical Structure[edit]
Thioacetazone is a thiosemicarbazone derivative, characterized by its sulfur-containing moiety. The chemical structure of thioacetazone includes a thiosemicarbazone group attached to an aromatic ring, which is crucial for its antibacterial activity.
Mechanism of Action[edit]
Thioacetazone works by inhibiting the synthesis of mycolic acids, essential components of the mycobacterial cell wall. This inhibition disrupts the integrity of the cell wall, leading to the death of the bacterium. The drug is bacteriostatic, meaning it inhibits the growth and reproduction of bacteria rather than killing them directly.
Clinical Use[edit]
Thioacetazone is used in combination with other antitubercular drugs such as isoniazid and rifampicin. It is particularly useful in the treatment of drug-resistant TB strains. However, its use has declined in many parts of the world due to the availability of more effective and less toxic alternatives.
Side Effects[edit]
The use of thioacetazone is associated with several side effects, the most significant being skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis. These severe skin reactions are more common in patients with HIV/AIDS, which has led to caution in its use among these populations.
History[edit]
Thioacetazone was first introduced in the 1940s as a treatment for tuberculosis. It gained popularity due to its low cost and effectiveness in combination therapy. However, the emergence of severe side effects and the development of more effective drugs have limited its use in modern TB treatment regimens.
Related Pages[edit]
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian